Drug maker Purdue Pharma has introduced a new educational resource for healthcare professionals designed to curb the abuse of prescription drugs, the company said Monday.
Kmart is introducing prescription pet medications at its stores, the mass merchandise retail chain said Friday.
The number of new drug shortages has been halved as early notifications from manufacturers of potential shortages have increased sixfold, the commissioner of the Food and Drug Administration wrote Thursday.
Drug maker Johnson & Johnson is seeking approval from the Food and Drug Administration for a drug to treat patients with deep vein thrombosis or pulmonary embolism, the company said.
Drug makers could strike big with new treatments for rare diseases, according to a new report by a market research firm.
The Food and Drug Administration has approved a new treatment for a rare genetic disorder that affects 10,000 people worldwide.
Eisai announced that Allen Waxman has joined the company.
Mylan will be barred from marketing a generic version of a Merck cardiovascular drug until the drug's patent expires, under a court ruling announced Friday.
An online plea for help from a mother dying of breast cancer prompted the manufacturer of an experimental drug to release it early, according to published reports.
The Food and Drug Administration has approved a drug made by GlaxoSmithKline for certain cancer patients.
A drug made by Novartis has received approval from the Food and Drug Administration to treat benign kidney tumors related to tuberous sclerosis complex.
The Food and Drug Administration has approved a new drug for treating erectile dysfunction, the agency said Friday.
The Food and Drug Administration declined to approve a drug made by Takeda Pharmaceutical, the drug maker said.
Drug makers in the United States are developing nearly 300 vaccines for preventing and treating diseases, according to a new report by a drug industry trade group.
Biotech drug maker Amgen is buying a pharmaceutical company based in Turkey, the companies said Wednesday.
GlaxoSmithKline said its offer to buy Human Genome Sciences was "full and fair" Wednesday after HGS turned it down last week, according to published reports.
George Rathmann, Amgen's founding CEO, has passed away, the drug maker announced Monday.
Globalization has led to a rapid increase in the drugs and foods arriving on U.S. shores from abroad, a trend that has prompted U.S. regulators to transform their approach.
Anglo-Swedish drug maker AstraZeneca will buy a San Diego-based biotech company for $1.26 billion, the two said Monday.
Watson Pharmaceuticals announced the launch of an authorized generic version of a drug used to lower blood glucose in patients with Type 2 diabetes.
More than 250 executives joined Anda for its 5th Annual Supply Chain Symposium here Thursday and Friday.
Merck is testing two means of treating patients with chronic hepatitis C for anemia, a common side effect of certain treatments for the viral infection, the drug maker said.
Roche has decided not to buy diagnostics firm Illumina, the drug maker said Wednesday.
Valeant Pharmaceuticals International is acquiring "certain assets" of a drug maker based in Mexico.
A U.S. drug maker has made a deal with a Swiss company to manufacture and sell a new osteoporosis treatment in North America.